Structure

Physi-Chem Properties

Molecular Weight:  568.29
Volume:  550.221
LogP:  0.562
LogD:  -0.137
LogS:  -3.116
# Rotatable Bonds:  4
TPSA:  193.44
# H-Bond Aceptor:  11
# H-Bond Donor:  8
# Rings:  6
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.236
Synthetic Accessibility Score:  5.649
Fsp3:  0.862
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.681
MDCK Permeability:  4.925940447719768e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  1.0
Human Intestinal Absorption (HIA):  0.907
20% Bioavailability (F20%):  0.998
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.145
Plasma Protein Binding (PPB):  53.586524963378906%
Volume Distribution (VD):  0.395
Pgp-substrate:  25.870149612426758%

ADMET: Metabolism

CYP1A2-inhibitor:  0.004
CYP1A2-substrate:  0.771
CYP2C19-inhibitor:  0.004
CYP2C19-substrate:  0.164
CYP2C9-inhibitor:  0.003
CYP2C9-substrate:  0.045
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.082
CYP3A4-inhibitor:  0.201
CYP3A4-substrate:  0.064

ADMET: Excretion

Clearance (CL):  1.975
Half-life (T1/2):  0.671

ADMET: Toxicity

hERG Blockers:  0.156
Human Hepatotoxicity (H-HT):  0.51
Drug-inuced Liver Injury (DILI):  0.016
AMES Toxicity:  0.036
Rat Oral Acute Toxicity:  0.814
Maximum Recommended Daily Dose:  0.962
Skin Sensitization:  0.357
Carcinogencity:  0.877
Eye Corrosion:  0.003
Eye Irritation:  0.01
Respiratory Toxicity:  0.98

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC275061

Natural Product ID:  NPC275061
Common Name*:   2,5,6-Trimethoxyphenanthrene-1,7-Diol
IUPAC Name:   2,5,6-trimethoxyphenanthrene-1,7-diol
Synonyms:  
Standard InCHIKey:  QRWFGIYPPNJHCO-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C17H16O5/c1-20-13-7-6-10-11(15(13)19)5-4-9-8-12(18)16(21-2)17(22-3)14(9)10/h4-8,18-19H,1-3H3
SMILES:  COc1ccc2c(ccc3cc(c(c(c23)OC)OC)O)c1O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL254598
PubChem CID:   24762423
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000025] Phenanthrenes and derivatives
        • [CHEMONTID:0003007] Phenanthrols

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota n.a. n.a. n.a. PMID[11575955]
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota stems Yunnan Province, China 2004 PMID[17253844]
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota Stems purchased from Kyoungdong Oriental Herbal Market, Seoul, Korea 2006-APR PMID[18052323]
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota Stems n.a. n.a. PMID[27310249]
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 54100.0 nM PMID[522707]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC275061 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC243996
1.0 High Similarity NPC132804
1.0 High Similarity NPC220344
0.9924 High Similarity NPC230919
0.9924 High Similarity NPC266453
0.9924 High Similarity NPC22902
0.9924 High Similarity NPC12668
0.9924 High Similarity NPC242715
0.9924 High Similarity NPC56329
0.9924 High Similarity NPC308768
0.9924 High Similarity NPC200935
0.9848 High Similarity NPC218131
0.9848 High Similarity NPC243759
0.9848 High Similarity NPC105847
0.9847 High Similarity NPC30632
0.9776 High Similarity NPC183709
0.9776 High Similarity NPC175838
0.9773 High Similarity NPC151656
0.9773 High Similarity NPC266006
0.9771 High Similarity NPC69029
0.9771 High Similarity NPC241241
0.9771 High Similarity NPC158142
0.9771 High Similarity NPC10314
0.9771 High Similarity NPC108198
0.9771 High Similarity NPC200557
0.9771 High Similarity NPC294884
0.9697 High Similarity NPC202846
0.9697 High Similarity NPC143139
0.9695 High Similarity NPC125649
0.9627 High Similarity NPC165026
0.9627 High Similarity NPC295719
0.9627 High Similarity NPC73505
0.9627 High Similarity NPC34431
0.9621 High Similarity NPC313081
0.9552 High Similarity NPC79622
0.9552 High Similarity NPC29868
0.9552 High Similarity NPC212942
0.9545 High Similarity NPC160697
0.9542 High Similarity NPC228843
0.9478 High Similarity NPC25111
0.9478 High Similarity NPC6262
0.9478 High Similarity NPC201145
0.9478 High Similarity NPC272157
0.9478 High Similarity NPC90615
0.9478 High Similarity NPC73535
0.9466 High Similarity NPC149337
0.9466 High Similarity NPC471983
0.9412 High Similarity NPC472089
0.9407 High Similarity NPC184613
0.9403 High Similarity NPC476639
0.9403 High Similarity NPC300846
0.9403 High Similarity NPC114155
0.9403 High Similarity NPC205442
0.9398 High Similarity NPC209199
0.9394 High Similarity NPC161958
0.9394 High Similarity NPC14224
0.9389 High Similarity NPC126836
0.9353 High Similarity NPC126291
0.9343 High Similarity NPC472087
0.9343 High Similarity NPC472088
0.9328 High Similarity NPC261873
0.9328 High Similarity NPC283009
0.9328 High Similarity NPC111655
0.9323 High Similarity NPC32778
0.9318 High Similarity NPC15543
0.9286 High Similarity NPC262297
0.9265 High Similarity NPC6300
0.9265 High Similarity NPC114171
0.9265 High Similarity NPC230124
0.9254 High Similarity NPC103967
0.9237 High Similarity NPC28765
0.9237 High Similarity NPC154866
0.9237 High Similarity NPC215300
0.9209 High Similarity NPC469795
0.9203 High Similarity NPC470917
0.9197 High Similarity NPC472090
0.9197 High Similarity NPC472092
0.9197 High Similarity NPC472091
0.9185 High Similarity NPC256262
0.9173 High Similarity NPC282508
0.916 High Similarity NPC124452
0.916 High Similarity NPC82679
0.916 High Similarity NPC236760
0.916 High Similarity NPC252131
0.916 High Similarity NPC74817
0.916 High Similarity NPC159968
0.916 High Similarity NPC53781
0.916 High Similarity NPC236791
0.916 High Similarity NPC471986
0.916 High Similarity NPC324112
0.916 High Similarity NPC169474
0.916 High Similarity NPC266555
0.916 High Similarity NPC293054
0.916 High Similarity NPC246620
0.916 High Similarity NPC282000
0.9137 High Similarity NPC469630
0.913 High Similarity NPC265075
0.9124 High Similarity NPC55947
0.9111 High Similarity NPC206737
0.9111 High Similarity NPC56764
0.9111 High Similarity NPC469659
0.9111 High Similarity NPC188378
0.9111 High Similarity NPC555
0.9111 High Similarity NPC276026
0.9111 High Similarity NPC289258
0.9111 High Similarity NPC7515
0.9104 High Similarity NPC218884
0.9091 High Similarity NPC23012
0.9091 High Similarity NPC38017
0.9084 High Similarity NPC18924
0.9084 High Similarity NPC214406
0.9084 High Similarity NPC44748
0.9084 High Similarity NPC78974
0.9084 High Similarity NPC223953
0.9084 High Similarity NPC223136
0.9084 High Similarity NPC28730
0.9084 High Similarity NPC170485
0.9084 High Similarity NPC103823
0.9078 High Similarity NPC233980
0.9065 High Similarity NPC191231
0.9051 High Similarity NPC35550
0.9044 High Similarity NPC180602
0.9044 High Similarity NPC214853
0.9044 High Similarity NPC240279
0.9044 High Similarity NPC37410
0.9044 High Similarity NPC55239
0.9015 High Similarity NPC21563
0.9015 High Similarity NPC127587
0.9014 High Similarity NPC474397
0.9008 High Similarity NPC113495
0.9008 High Similarity NPC472093
0.9008 High Similarity NPC208950
0.9008 High Similarity NPC299584
0.9008 High Similarity NPC57490
0.9008 High Similarity NPC105031
0.9008 High Similarity NPC221077
0.9008 High Similarity NPC475169
0.9008 High Similarity NPC265483
0.9008 High Similarity NPC116907
0.9008 High Similarity NPC105925
0.9008 High Similarity NPC298757
0.9008 High Similarity NPC251855
0.9008 High Similarity NPC60885
0.9008 High Similarity NPC117214
0.9008 High Similarity NPC234400
0.9008 High Similarity NPC82483
0.9008 High Similarity NPC233410
0.9008 High Similarity NPC203133
0.9008 High Similarity NPC193544
0.9008 High Similarity NPC17943
0.8993 High Similarity NPC71046
0.8986 High Similarity NPC260741
0.8986 High Similarity NPC32630
0.8986 High Similarity NPC70682
0.8978 High Similarity NPC206525
0.8978 High Similarity NPC472648
0.8978 High Similarity NPC472649
0.8978 High Similarity NPC133463
0.8978 High Similarity NPC133025
0.8978 High Similarity NPC472647
0.8978 High Similarity NPC170328
0.8978 High Similarity NPC191462
0.8971 High Similarity NPC311256
0.8963 High Similarity NPC303144
0.8963 High Similarity NPC6451
0.8955 High Similarity NPC299221
0.8955 High Similarity NPC234488
0.8955 High Similarity NPC311680
0.8955 High Similarity NPC51840
0.8955 High Similarity NPC254000
0.8939 High Similarity NPC76451
0.8936 High Similarity NPC473845
0.8936 High Similarity NPC50250
0.8936 High Similarity NPC473108
0.8931 High Similarity NPC224342
0.8931 High Similarity NPC5796
0.8931 High Similarity NPC138248
0.8931 High Similarity NPC228503
0.8931 High Similarity NPC206487
0.8929 High Similarity NPC277784
0.8921 High Similarity NPC198038
0.8921 High Similarity NPC266650
0.8921 High Similarity NPC234568
0.8913 High Similarity NPC3072
0.8913 High Similarity NPC46277
0.8913 High Similarity NPC301765
0.8913 High Similarity NPC156948
0.8913 High Similarity NPC71465
0.8913 High Similarity NPC472646
0.8913 High Similarity NPC86605
0.8905 High Similarity NPC258780
0.8897 High Similarity NPC36661
0.8889 High Similarity NPC232275
0.8889 High Similarity NPC12275
0.8889 High Similarity NPC45715
0.8889 High Similarity NPC474356
0.8881 High Similarity NPC58164
0.8881 High Similarity NPC212015
0.8881 High Similarity NPC10225
0.8872 High Similarity NPC473221

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC275061 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8741 High Similarity NPD3027 Phase 3
0.8603 High Similarity NPD4625 Phase 3
0.8529 High Similarity NPD1529 Clinical (unspecified phase)
0.8456 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.8417 Intermediate Similarity NPD1613 Approved
0.8417 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8406 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD6232 Discontinued
0.8261 Intermediate Similarity NPD4908 Phase 1
0.8165 Intermediate Similarity NPD7473 Discontinued
0.8058 Intermediate Similarity NPD3018 Phase 2
0.8028 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.8028 Intermediate Similarity NPD3620 Phase 2
0.8013 Intermediate Similarity NPD6234 Discontinued
0.795 Intermediate Similarity NPD5844 Phase 1
0.7922 Intermediate Similarity NPD37 Approved
0.7899 Intermediate Similarity NPD2983 Phase 2
0.7899 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7899 Intermediate Similarity NPD4749 Approved
0.7899 Intermediate Similarity NPD2982 Phase 2
0.7883 Intermediate Similarity NPD1610 Phase 2
0.7879 Intermediate Similarity NPD5283 Phase 1
0.7863 Intermediate Similarity NPD228 Approved
0.7857 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7838 Intermediate Similarity NPD6674 Discontinued
0.7838 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD2981 Phase 2
0.7778 Intermediate Similarity NPD4060 Phase 1
0.7771 Intermediate Similarity NPD4967 Phase 2
0.7771 Intermediate Similarity NPD4966 Approved
0.7771 Intermediate Similarity NPD4965 Approved
0.7762 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7756 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7721 Intermediate Similarity NPD1548 Phase 1
0.7692 Intermediate Similarity NPD1934 Approved
0.7688 Intermediate Similarity NPD7199 Phase 2
0.7671 Intermediate Similarity NPD4097 Suspended
0.7669 Intermediate Similarity NPD7228 Approved
0.7643 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD2801 Approved
0.7609 Intermediate Similarity NPD4626 Approved
0.7593 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD3021 Approved
0.7576 Intermediate Similarity NPD3022 Approved
0.7557 Intermediate Similarity NPD2342 Discontinued
0.7547 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD6166 Phase 2
0.75 Intermediate Similarity NPD4005 Discontinued
0.7469 Intermediate Similarity NPD6959 Discontinued
0.7467 Intermediate Similarity NPD3540 Phase 1
0.7456 Intermediate Similarity NPD8053 Approved
0.7456 Intermediate Similarity NPD8054 Approved
0.7444 Intermediate Similarity NPD4750 Phase 3
0.7438 Intermediate Similarity NPD3882 Suspended
0.7431 Intermediate Similarity NPD2861 Phase 2
0.7421 Intermediate Similarity NPD1465 Phase 2
0.7419 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD1651 Approved
0.7403 Intermediate Similarity NPD1511 Approved
0.74 Intermediate Similarity NPD6100 Approved
0.74 Intermediate Similarity NPD3539 Phase 1
0.74 Intermediate Similarity NPD6099 Approved
0.7391 Intermediate Similarity NPD4055 Discovery
0.7376 Intermediate Similarity NPD3705 Approved
0.7351 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7343 Intermediate Similarity NPD6696 Suspended
0.7343 Intermediate Similarity NPD1283 Approved
0.7343 Intermediate Similarity NPD8651 Approved
0.7325 Intermediate Similarity NPD1653 Approved
0.7308 Intermediate Similarity NPD1512 Approved
0.7308 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD1558 Phase 1
0.729 Intermediate Similarity NPD7040 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD7041 Phase 2
0.7286 Intermediate Similarity NPD5691 Approved
0.7283 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7279 Intermediate Similarity NPD7635 Approved
0.7273 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7251 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD3657 Discovery
0.7248 Intermediate Similarity NPD5735 Approved
0.7244 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD7447 Phase 1
0.7244 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD4624 Approved
0.7233 Intermediate Similarity NPD4380 Phase 2
0.7226 Intermediate Similarity NPD7124 Phase 2
0.7222 Intermediate Similarity NPD7768 Phase 2
0.7212 Intermediate Similarity NPD7229 Phase 3
0.7208 Intermediate Similarity NPD7003 Approved
0.7208 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD3750 Approved
0.7205 Intermediate Similarity NPD7819 Suspended
0.72 Intermediate Similarity NPD1607 Approved
0.7179 Intermediate Similarity NPD4357 Discontinued
0.7179 Intermediate Similarity NPD7213 Phase 3
0.7179 Intermediate Similarity NPD7212 Phase 2
0.7179 Intermediate Similarity NPD7390 Discontinued
0.7176 Intermediate Similarity NPD7240 Approved
0.7176 Intermediate Similarity NPD940 Approved
0.7176 Intermediate Similarity NPD6559 Discontinued
0.7176 Intermediate Similarity NPD846 Approved
0.7172 Intermediate Similarity NPD3094 Phase 2
0.7162 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7162 Intermediate Similarity NPD5109 Approved
0.7162 Intermediate Similarity NPD5111 Phase 2
0.7162 Intermediate Similarity NPD5110 Phase 2
0.716 Intermediate Similarity NPD7074 Phase 3
0.716 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD3817 Phase 2
0.7153 Intermediate Similarity NPD1669 Approved
0.7143 Intermediate Similarity NPD5536 Phase 2
0.7143 Intermediate Similarity NPD3818 Discontinued
0.7134 Intermediate Similarity NPD2533 Approved
0.7134 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD2534 Approved
0.7134 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD2532 Approved
0.7133 Intermediate Similarity NPD3092 Approved
0.7133 Intermediate Similarity NPD1281 Approved
0.7133 Intermediate Similarity NPD422 Phase 1
0.7133 Intermediate Similarity NPD1611 Approved
0.7124 Intermediate Similarity NPD5763 Approved
0.7124 Intermediate Similarity NPD5762 Approved
0.7123 Intermediate Similarity NPD6584 Phase 3
0.7117 Intermediate Similarity NPD4581 Clinical (unspecified phase)
0.7113 Intermediate Similarity NPD2286 Discontinued
0.7105 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD1510 Phase 2
0.7101 Intermediate Similarity NPD7054 Approved
0.7101 Intermediate Similarity NPD4869 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD1242 Phase 1
0.7097 Intermediate Similarity NPD3892 Phase 2
0.7095 Intermediate Similarity NPD7095 Approved
0.7091 Intermediate Similarity NPD5494 Approved
0.7081 Intermediate Similarity NPD5090 Approved
0.7081 Intermediate Similarity NPD5089 Approved
0.7078 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD7075 Discontinued
0.7067 Intermediate Similarity NPD1240 Approved
0.7063 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD5406 Approved
0.7059 Intermediate Similarity NPD2438 Suspended
0.7059 Intermediate Similarity NPD5404 Approved
0.7059 Intermediate Similarity NPD2935 Discontinued
0.7059 Intermediate Similarity NPD7472 Approved
0.7059 Intermediate Similarity NPD5408 Approved
0.7059 Intermediate Similarity NPD5451 Approved
0.7059 Intermediate Similarity NPD5405 Approved
0.7051 Intermediate Similarity NPD5241 Discontinued
0.7047 Intermediate Similarity NPD6812 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD6798 Discontinued
0.7041 Intermediate Similarity NPD8252 Approved
0.7041 Intermediate Similarity NPD8251 Approved
0.7041 Intermediate Similarity NPD8099 Discontinued
0.7039 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD4536 Approved
0.7039 Intermediate Similarity NPD4538 Approved
0.7039 Intermediate Similarity NPD6111 Discontinued
0.7035 Intermediate Similarity NPD7549 Discontinued
0.7035 Intermediate Similarity NPD8453 Clinical (unspecified phase)
0.7034 Intermediate Similarity NPD5327 Phase 3
0.7032 Intermediate Similarity NPD3060 Approved
0.7032 Intermediate Similarity NPD5177 Phase 3
0.7029 Intermediate Similarity NPD7906 Approved
0.7024 Intermediate Similarity NPD27 Approved
0.7024 Intermediate Similarity NPD2489 Approved
0.702 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD5124 Phase 1
0.7019 Intermediate Similarity NPD4678 Approved
0.7019 Intermediate Similarity NPD4675 Approved
0.7018 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD7266 Discontinued
0.7012 Intermediate Similarity NPD6788 Approved
0.7011 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD3051 Approved
0.7 Intermediate Similarity NPD6671 Approved
0.7 Intermediate Similarity NPD2674 Phase 3
0.7 Intermediate Similarity NPD7157 Approved
0.7 Intermediate Similarity NPD709 Approved
0.7 Intermediate Similarity NPD8156 Discontinued
0.6994 Remote Similarity NPD5929 Approved
0.6994 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6994 Remote Similarity NPD4577 Approved
0.6994 Remote Similarity NPD4578 Approved
0.6993 Remote Similarity NPD4108 Discontinued
0.6993 Remote Similarity NPD5126 Approved
0.6993 Remote Similarity NPD6516 Phase 2
0.6993 Remote Similarity NPD5125 Phase 3
0.6993 Remote Similarity NPD5846 Approved
0.6988 Remote Similarity NPD4666 Phase 3
0.6988 Remote Similarity NPD6746 Phase 2
0.6987 Remote Similarity NPD6331 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data